Abstract
Dual-energy X-ray absorptiometry (DXA) scans to measure bone mineral density (BMD) at the spine and hip have an important role in the evaluation of individuals at risk of sustaining an osteoporosis-related fracture and in helping clinicians advise patients about the appropriate use of anti-fracture treatment. Compared with alternative bone densitometry techniques, hip and spine DXA examinations have a number of advantages that include a consensus that BMD results should be interpreted using the World Health Organization (WHO) T-score definition of osteoporosis, a proven ability to predict fracture risk, proven effectiveness at targeting anti-fracture therapies, and the ability to monitor response to treatment. This review discusses the evidence for these and other clinical aspects of DXA scanning. Particular attention is paid to the new WHO FRAX® algorithm, which uses clinical risk factors in combination with a hip DXA scan to predict a patient’s 10-year risk of experiencing an osteoporotic fracture. We review the recently published clinical guidelines that incorporate the FRAX fracture risk assessment tool in decisions about patient treatment and discuss the reasons why a quantitative evaluation of fracture risk should become the standard approach to the clinical interpretation of DXA examinations in postmenopausal women and older men.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams JE, Ahmed SF, Alsop C et al (2004) A practical guide to bone densitometry in children. National Osteoporosis Society, Bath
Barr RJ, Adebajo A, Fraser WD et al (2005) Can peripheral DXA measurements be used to predict fractures in elderly women living in the community? Osteoporos Int 16:1177–1183
Bell KJL, Hayen A, Macaskill P et al (2009) Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ 338:b2266
Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541
Black DM, Palermo L, Bauer D (2000) How well does bone mass predict long-term risk of hip fracture? Osteoporos Int 11(Suppl 2):S59
Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822
Blake GM, Fogelman I (1997) Technical principles of dual-energy x-ray absorptiometry. Semin Nucl Med 27:210–228
Blake GM, Fogelman I (2001) Peripheral or central densitometry: does it matter which technique we use? J Clin Densitom 4:83–96
Blake GM, Fogelman I (2002) Clinical use of instruments that measure peripheral bone mass. Curr Opin Endocrinol Diabetes 9:502–511
Blake GM, Fogelman I (2008) How important are BMD accuracy errors for the clinical interpretation of DXA scans? J Bone Miner Res 23:457–462
Blake GM, Herd RJM, Fogelman I (1996) A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporos Int 6:462–470
Blake GM, Patel R, Knapp KM, Fogelman I (2003) Does the combination of two BMD measurements improve fracture discrimination? J Bone Miner Res 18:1955–1963
Blake GM, Chinn DJ, Steel SA et al (2005) A list of device specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int 16:2149–2156
Bonnick SL, Johnston CC Jr, Kleerekoper M et al (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105–110
Borgstrom F, Jonsson B, Strom O, Kanis JA (2006a) An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting based on the results of the SOTI and TROPOS trials. Osteoporos Int 17:1781–1793
Borgstrom F, Carisson A, Sintonen H et al (2006b) Cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporos Int 17:996–1007
Borgstrom F, Johnell O, Kanis JA et al (2006c) At what hip fracture risk is it cost effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 17:1459–1471
Centre JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fractures in men and women: an observational study. Lancet 353:878–882
Chesnut CH, Skag A, Christiansen C et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241–1249
Compston J (2009) Monitoring bone mineral density during antiresorptive treatment for osteoporosis. BMJ 338:b1276
Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon M, Melton LJ (1993) Population based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001–1005
Cummings SR, Bauer DC (2010) Filtering FRAX – Don’t filter FRAX. Osteoporos Int 21:537–541
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767
Cummings SR, Black DM, Nevitt MC et al (1993) Bone density at various sites for prediction of hip fractures. Lancet 341:72–75
Cummings SR, Black DM, Thompson DE et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA 280:2077–2082
Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765
De Laet C, Oden A, Johansson H, Johnell O, Jonsson B, Kanis JA (2005a) The impact of the use of multiple risk factors for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16:313–318
De Laet C, Kanis JA, Oden A et al (2005b) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338
Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611–617
Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736–746
Eriksson S, Isberg B, Lindgren U (1988) Vertebral bone mineral measurement using dual photon absorptiometry and computed tomography. Acta Radiol 29:89–94
Ettinger B, Black DM, Mitlak BH et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282:637–645
Faulkner KG (1998) Bone densitometry: choosing the proper site to measure. J Clin Densitom 1:279–285
Faulkner KG, Roberts LA, McClung MR (1996) Discrepancies in normative data between lunar and hologic DXA systems. Osteoporos Int 6:432–436
Faulkner KG, Von Stetton E, Miller P (1999) Discordance in patient classification using T-scores. J Clin Densitom 2:343–350
Fink HA, Harrison SL, Taylor BC et al (2008) Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. J Clin Densitom 11:250–259
Fogelman I, Blake GM (2000) Different approaches to bone densitometry. J Nucl Med 41:2015–2025
FRAX (2008) FRAX-WHO fracture risk assessment tool. http://www.shef.ac.uk/FRAX. Accessed 27 Apr 2010
Genant HK, Engelke K, Fuerst T et al (1996) Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 11:707–730
Gluer C-C (1999) Monitoring skeletal change by radiological techniques. J Bone Miner Res 14:1952–1962
Gluer C-C, Blake G, Lu Y et al (1995) Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int 5:262–270
Gotfredsen A, Podenphant J, Norgaard H et al (1988) Accuracy of lumbar spine bone mineral content by dual photon absorptiometry. J Nucl Med 29:248–254
Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831–838
Guglielmi G, Lang TF (2002) Quantitative computed tomography. Semin Musculoskelet Radiol 6:219–227
Hanson J (1997) Standardization of femur BMD. J Bone Miner Res 12:1316–1317
Harris ST, Watts NB, Genant HK et al (1999) Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. JAMA 282:1344–1352
Ho CP, Kim RW, Schaffler MB, Sartoris DJ (1990) Accuracy of dual-energy radiographic of the lumbar spine: a cadaver study. Radiology 176:171–173
Holland WW, Whitehead TP (1974) Value of new laboratory tests in diagnosis and treatment. Lancet 304:391–394
ISCD (2007) Official positions of the international society for clinical densitometry: updated 2007. http://www.iscd.org/visitors/positions/official.cfm. Accessed 27 Apr 2010
Johansson H, Oden A, Johnell O et al (2004) Optimisation of BMD measurements to identify high risk groups for treatment – a test analysis. J Bone Miner Res 19:906–913
Johnell O, Kanis JA, Oden A et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194
Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:929–936
Kanis JA, Gluer CC (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202
Kanis JA, Johnell O, Oden A et al (2001a) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995
Kanis JA, Oden A, Johnell O et al (2001b) The burden of osteoporotic fractures: a method of setting intervention thresholds. Osteoporos Int 12:417–427
Kanis JA, Black D, Cooper C et al (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13:527–536
Kanis JA, Johansson H, Oden A et al (2004a) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037
Kanis JA, Johansson H, Oden A et al (2004b) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893–899
Kanis JA, Johnell O, De Laet C et al (2004c) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382
Kanis JA, Borgstrom F, De Laet C et al (2005a) Assessment of fracture risk. Osteoporos Int 16:581–589
Kanis JA, Johnell O, Oden A et al (2005b) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162
Kanis JA, Johansson H, Johnell O et al (2005c) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742
Kanis JA, Borgstrom F, Johnell O et al (2005d) Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int 16:15–25
Kanis JA, Borgstrom F, Zethraeus N et al (2005e) Intervention thresholds for osteoporosis in the UK. Bone 36:22–32
Kanis JA, Johnell O, Oden A et al (2006) The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int 17:527–534
Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046
Kanis JA, Johnell O, Oden A et al (2008a) FRAX and the assessment of facture probability in men and women from the UK. Osteoporos Int 19:385–397
Kanis JA, McCloskey EV, Johansson H et al (2008b) Case finding for the management of osteoporosis with FRAX – assessment and intervention thresholds for the UK. Osteoporos Int 19:1395–1408
Kanis JA, McCloskey EV, Johansson H et al (2008c) A reference standard for the description of osteoporosis. Bone 42:467–475
Kaptoge S, da Silva JA, Brixen K et al (2008) Geographical variation in DXA bone mineral density in young European men and women. Results from the network in Europe on male osteoporosis (NEMO) study. Bone 43:332–339
Kuiper JW, van Kuijk C, Grashusi JL et al (1996) Accuracy and the influence of marrow fat on quantitative CT and dual-energy x-ray absorptiometry measurements of the femoral neck in vitro. Osteoporos Int 6:25–30
Lang TF, Guglielmi G, Van Kuijk C et al (2002) Measurement of vertebral bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30:247–250
Lee DC, Wren TAL, Gilanz V (2007) Correcting DXA pediatric bone mineral density measurements to account for fat inhomogeneity. J Bone Miner Res 22(Suppl 1):S494–S495
Lehmann LA, Alvaez RE, Macovski A et al (1981) Generalized image combinations in dual KVP digital radiography. Med Phys 8:659–667
Looker AC, Wahner HW, Dunn WL et al (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489
Lu Y, Genant HK, Shepherd J et al (2001) Classification of osteoporosis based on bone mineral densities. J Bone Miner Res 16:901–910
Lunt M, Felsenberg D, Adams J et al (1997) Population-based geographic variations in DXA bone density in Europe: the EVOS study. Osteoporos Int 7:175–189
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312: 1254–1259
McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy–additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20:811–817
McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate treatment on hip fracture risk in elderly women. N Engl J Med 344:333–340
Melton LJ, Gabriel SE, Crowson CS et al (2003) Cost-equivalence of different osteoporotic fractures. Osteoporos Int 14:383–388
Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468
Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of recombinant human parathyroid hormone (1–34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N Engl J Med 344:1434–1441
NOF (2008a) National osteoporosis foundation fast facts on osteoporosis. http://www.nof.org/professionals/Clinicians_Guide.htm. Accessed 27 Apr 2010
NOF (2008b) National osteoporosis foundation clinician’s guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/index.htm. Accessed 27 Apr 2010
NOGG (2008) National Osteoporosis Guideline Group. http://www.shef.ac.uk/NOGG/index.html. Accessed 27 Apr 2010
Noon E, Singh S, Cuzick J et al (2010) Significant differences in UK and US female bone density reference ranges. Osteoporos Int 21(11):1871–1880
Patel R, Blake GM, Rymer J, Fogelman I (2000) Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11:68–75
Reginster JY, Seeman E, De Vernejoul MC et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J Clin Endocrinol Metab 90:2816–2822
Sabin MA, Blake GM, MacLaughlin-Black SM, Fogelman I (1995) The accuracy of volumetric bone density measurements in dual X-ray absorptiometry. Calcif Tissue Int 56:210–214
Seeman E, Vellas B, Benhamou C et al (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21:1113–1120
Shepherd JA, Fan B, Lu Y et al (2006) Comparison of BMD precision for prodigy and Delphi spine and femur scans. Osteoporos Int 17:1303–1308
Stewart A, Reid DM (2002) Quantitative ultrasound in osteoporosis. Semin Musculoskelet Radiol 6:229–232
Stone KL, Seeley DG, Lui L-Y et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954
Storm T, Thamsborg G, Steiniche T et al (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265–1271
Svendsen OL, Hassager C, Skodt V, Christiansen C (1995) Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip and forearm: a human cadaver study. J Bone Miner Res 10:868–873
Tothill P, Pye DW (1992) Errors due to non-uniform distribution of fat in dual x-ray absorptiometry of the lumbar spine. Br J Radiol 65:807–813
Tothill P, Pye DW, Teper J (1989) The influence of extra-skeletal fat on the accuracy of dual photon absorptiometry of the spine. In: Ring EFJ, Evans WD, Dixon AS (eds) Osteoporosis and bone mineral measurement. ISPM, York, pp 48–53
Wahner HW, Dunn WL, Mazess RB et al (1985) Dual photon Gd-153 absorptiometry of bone. Radiology 156:203–206
Ward KA, Ashby RL, Roberts SA et al (2007) UK reference data for the hologic QDR discovery dual-energy x-ray absorptiometry scanner in healthy children and young adults aged 6–17 years. Arch Dis Child 92:53–59
Webber CE (1987) The effect of fat on bone mineral measurements in normal subjects with recommended values of bone, muscle and fat attenuation coefficients. Clin Phys Physiol Meas 8:143–157
WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series 843. WHO, Geneva
Zethraeus N, Borgstrom F, Strom O, Kanis JA (2007) Cost-effectiveness of the treatment and prevention of osteoporosis – a review of the literature and a reference model. Osteoporos Int 18:9–23
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Blake, G.M., Fogelman, I. (2012). Bone Densitometry: Science and Practice. In: Fogelman, I., Gnanasegaran, G., van der Wall, H. (eds) Radionuclide and Hybrid Bone Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02400-9_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-02400-9_38
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02399-6
Online ISBN: 978-3-642-02400-9
eBook Packages: MedicineMedicine (R0)